Age-Related Changes in the Hepatic Pharmacology and Toxicology of Paracetamol
2011

Age-Related Changes in the Hepatic Pharmacology and Toxicology of Paracetamol

publication Evidence: moderate

Author Information

Author(s): Sarah J. Mitchell, Alice E. Kane, Sarah N. Hilmer

Primary Institution: National Institute on Aging, National Institutes of Health

Hypothesis

How do age-related changes affect the hepatic pharmacology and toxicity of paracetamol?

Conclusion

Understanding how age affects the hepatic clearance and toxicity of paracetamol can lead to better prescribing practices for older adults.

Supporting Evidence

  • Paracetamol is one of the most studied agents that cause hepatotoxicity.
  • Age-related changes in liver size and blood flow significantly affect drug metabolism.
  • Older adults are at increased risk of adverse drug reactions due to altered pharmacokinetics.

Takeaway

As people get older, their bodies process paracetamol differently, which can make it more dangerous for them. This study helps doctors understand how to give the right amount to older patients.

Methodology

The paper reviews existing literature on age-related physiological changes and their impact on drug metabolism, particularly focusing on paracetamol.

Potential Biases

Potential biases may arise from the limited data on clinical outcomes of dose adjustments in older adults.

Limitations

The evidence base for dose adjustment in older people is limited, particularly in frail populations.

Participant Demographics

The study focuses on older adults, particularly those who are frail.

Digital Object Identifier (DOI)

10.1155/2011/624156

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication